Hepatitis C News and Research

Latest Hepatitis C News and Research

Mount Sinai researchers receive federal funding to treat HCV in primary care settings

With the number of people with chronic hepatitis C reaching record levels in New York City and the recent availability of more effective treatments, researchers from the Icahn School of Medicine at Mount Sinai recently announced the receipt of $1.9 million in federal funding to increase its capacity to treat HCV in primary care settings.

19 Aug 2014

ITS develops new T cell vaccine to protect humans from seasonal and pandemic influenza A

Immune Targeting Systems, specializing in the development of novel T cell immune therapies, has been developing an exciting new T cell vaccine (FlunisynTM) designed to protect humans from all strains of seasonal and pandemic influenza A.

18 Aug 2014

Physician disclosure website back on track

The Centers for Medicare & Medicaid Services announces it has fixed the glitch that took down the website where doctors and hospitals can review information about payments from drug and device makers. Meanwhile, The New York Times looks at how costly compounded medicines are drawing the ire of health insurers, and a U.K. agency recommends the government pay for a costly new hepatitis treatment.

16 Aug 2014

First Edition: August 15, 2014

Today's headlines include a variety of updates regarding health policy and the health care marketplace.

15 Aug 2014

Medical advisory panel recommends new pneumonia vaccine for seniors

The experts expressed concern, however, that Medicare rules may hamper some people from getting the new vaccine if they have already had an older version. Also in drug issues, some patient advocates report that insurers are balking at paying for a costly drug to treat hepatitis C if the patients are in drug treatment programs.

15 Aug 2014

First Edition: August 14, 2014

Today's headlines include a report about an uptick in VA referrals to private physicians. Kaiser Health News staff writer Julie Appleby reports: "Some hospitals in New York, Florida and Wisconsin are exploring ways to help individuals and families pay their share of the costs of government-subsidized policies purchased though the health law's marketplaces – at least partly to guarantee the hospitals get paid when the consumers seek care.

14 Aug 2014

Ebola virus defeats attempts by interferon to block viral reproduction in infected cells

One of the human body's first responses to a viral infection is to make and release signaling proteins called interferons, which amplify the immune system response to viruses.

14 Aug 2014

Inovio Pharmaceuticals reports increased revenue in second quarter 2014

Inovio Pharmaceuticals, Inc. today reported financial results for the quarter ended June 30, 2014. Total revenue was $3.8 million and $6.2 million for the three and six months ended June 30, 2014, compared to $786,000 and $2.2 million for the same periods in 2013.

11 Aug 2014

Viewpoints: Why Emory accepted American Ebola cases; calls for terrified Americans to 'chill out'

Blame it on Richard Preston. "The Hot Zone," his 1994 nonfiction science thriller about the spread and devastation of the Ebola virus, pretty much set the standard for terrifying contagion scenarios. ...

8 Aug 2014

Oncolytics Biotech announces financial results and operational highlights for second quarter 2014

Oncolytics Biotech Inc. today announced its financial results and operational highlights for the second quarter ended June 30, 2014.

7 Aug 2014

First MinuteClinic walk-in medical clinics in Nebraska

The first MinuteClinic walk-in medical clinics in Nebraska are opening this week inside select CVS/pharmacy stores. Two clinics opened yesterday in Lincoln and one is opening today in Omaha. A third clinic in Lincoln and three more clinics in the Omaha area will open later this month.

7 Aug 2014

American Journal of Public Health special issue to highlight health disparities among Veterans Affairs

In an online-only, open access special issue of the American Journal of Public Health, researchers investigate issues of health equity, quality and disparities within the Veterans Affairs health care system.

7 Aug 2014

Costly specialty drugs drive up Medicare tab

ProPublica and The New York Times look at the explosive spending growth from an obscure medication for treating multiple sclerosis and a rare kidney disease -- and how several top prescribers have links to drugmaker, Questcor Pharmaceuticals.

5 Aug 2014

First Edition: August 5, 2014

Today's headlines include coverage of a partnership between two of California's largest insurers in which they will join forces to create a database of patient medical records.

5 Aug 2014

Computer simulation forecasts favorable trends in eradicating hepatitis C

5 Aug 2014

Hepatitis C could become a rare disease by 2036

Effective new drugs and screening would make hepatitis C a rare disease by 2036, according to a computer simulation conducted by The University of Texas MD Anderson Cancer Center and the University of Pittsburgh Graduate School of Public Health. The results of the simulation are reported in the August 5 edition of the journal Annals of Internal Medicine.

5 Aug 2014

Hepatitis C News and Research

Latest Hepatitis C News and Research

Mount Sinai researchers receive federal funding to treat HCV in primary care settings

ITS develops new T cell vaccine to protect humans from seasonal and pandemic influenza A

Physician disclosure website back on track

First Edition: August 15, 2014

Medical advisory panel recommends new pneumonia vaccine for seniors

First Edition: August 14, 2014

Ebola virus defeats attempts by interferon to block viral reproduction in infected cells

Inovio Pharmaceuticals reports increased revenue in second quarter 2014

Viewpoints: Why Emory accepted American Ebola cases; calls for terrified Americans to 'chill out'

Oncolytics Biotech announces financial results and operational highlights for second quarter 2014

First MinuteClinic walk-in medical clinics in Nebraska

American Journal of Public Health special issue to highlight health disparities among Veterans Affairs

Costly specialty drugs drive up Medicare tab

First Edition: August 5, 2014

Computer simulation forecasts favorable trends in eradicating hepatitis C

Hepatitis C could become a rare disease by 2036

New technique for studying lifecycle of hepatitis B virus can help develop cure for disease

Viewpoints: Ignagni on prices of new drugs; Sen. Johnson on the difficulty of suing a president

Medicaid roundup: Florida receives 3-year renewal for managed care program; Illinois limits Sovaldi

First Edition: August 4, 2014

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Hepatitis C News and Research

Latest Hepatitis C News and Research

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Newsletters you may be interested in